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Caspase 8: igniting the death machine
Guy S Salvesen
Intense research into the signaling pathways of apoptosis
has revealed a dominant role for proteases belonging to
the caspase family, which in humans has 11 members at
present. Two papers in the September issue of Structure
with Folding & Design have for the first time revealed the
structure of the key apoptotic initiator, caspase 8. 
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Signaling by proteolysis
Limited proteolysis plays a dominant role in an organism’s
response to environmental and developmental cues.
Classic examples are the extracellular pathways leading to
blood coagulation and complement fixation in higher
animals, and gastrulation in flies. Over the past few years,
we can probably give 1992 as the discovery date, it has
become apparent that some important intracellular signal-
ing pathways are also driven almost exclusively by proteol-
ysis [1,2]. The proteases that form the framework of these
pathways — cytokine activation and apoptotic cell
death — belong to the caspase family (or family C14
in the Barrett and Rawlings nomenclature system
[http://www.bi.bbsrc.ac.uk/world/Labs/peptidase/merops.
HTM]). The involvement of caspases in cell death paral-
lels the development of apoptosis itself, with primitive
caspase family members being found in the prototypic
animal model Caenorhabditis elegans [3]. The pro-inflamma-
tory branch of the caspase family probably developed more
recently, presumably with the need for a rapid response of
the innate immune system to bacterial infection. The
death and pro-inflammatory pathways are apparently unre-
lated, at least during development, as reviewed in [4–6].
Ordered caspase pathways
The basic principle of a proteolytic pathway, whether in
blood coagulation or apoptosis, is to achieve activation of an
apical ‘initiator’ protease that can directly activate a down-
stream zymogen. The apoptosis field currently recognizes
two distinct pathways, an extrinsic and an intrinsic one, to
activation of the initiator caspases. The extrinsic pathway
conveys signals through ligation of members of the tumor
necrosis factor R1 (TNF-R1) death receptor family. Evolu-
tion has provided a number of death ligands elaborated by
distinct cell populations to engage their cognate receptors
on cells that need to die during development, education of
the immune system, or following viral infection (reviewed
in [7]). Thus the death receptors are conduits that convey
signals to the cells’ interior, where the apical proteases of
the extrinsic pathway, caspases 8 and 10, reside.
Cells must also die when they are irreparably damaged, and
the intrinsic pathway responds to the majority of these
types of signal. For example, cells suicide following serious
genome damage, treatment with anti-neoplastic drugs, and
some developmental signals, via a route involving pro-apop-
totic molecules associated with mitochondria [8,9]. Both
pathways converge to activate the downstream ‘execu-
tioner’ caspases, which are in turn responsible for limited
proteolysis of most of the proteins [10] that allow the apop-
totic phenotype of cell death to develop (Figure 1). 
As protease zymogens are almost always activated by pro-
teolysis, it is fairly easy to see how an active initiator could
power up the executioner caspases. However, the conun-
drum of how the initiators themselves are activated, how
the first proteolytic signal originates, was problematic until
quite recently. It seems that the zymogen of caspase 8
contains a small amount of proteolytic activity [11].
Although this activity is insufficient to drive apoptosis, it
is enough to allow intramolecular processing of zymogen
molecules at high concentration. In vivo the high concen-
tration is achieved by an ingenious mechanism of local
zymogen clustering at the cytosolic face of death recep-
tors, in a process modulated by homophilic protein inter-
actions through adapter proteins [11,12]. A similar process
occurs during activation of caspase 9 [13], but in this case
the adapter/activator proteins act as cofactors, increasing
catalytic rates by several thousand-fold [14].
Specificity
It is quite difficult to imagine how proteolytic pathways
have evolved. Why does it take several sequential prote-
olytic events to activate thrombin, the ‘executioner’ of the
coagulation cascade? Usually the speculations are to
amplify the signal, or to ensure its location to a specific
site, or to allow for several points of regulation before the
final proteolytic decision is made. Irrespective of the
reason, the existence of sequential proteolytic events in
the extrinsic pathway means that the initiators must have
a different specificity to the executioners. Thornberry and
colleagues’ seminal work put this issue into perspective;
they showed that one could divide the caspases into three
groups on the basis of their preferences for small peptide
derivatives [15,16] (Table 1).
Most of the proteins whose processing characterizes apop-
tosis (including nucleic acid modifiers, kinases, transcrip-
tion factors, cytoskeletal and nuclear scaffold components)
are cleaved after the DXXD (single-letter amino acid code
where X is any amino acid) motif, indicating that caspases
are 3 and 7 are the main effectors, and firmly placing them
at the execution phase. Occasionally, substrates are
cleaved after the (I/L/V)XXD motif, indicating a role for
the initiators, the most important of these being the exe-
cutioner zymogens themselves [10]. As pointed out by
Thornberry and colleagues, the processing sites in these
executioner zymogens fit the specificity of the initiators
particularly well. Overall, the specificities observed from
the use of synthetic substrates predict the real protein
targets, the cleavage of which is required to execute apop-
tosis. So an understanding of how this specificity is
achieved is crucial not only in describing the order of
caspase pathways, but also to the goal of devising effective
therapeutics to intervene in pathologies caused by inap-
propriate caspase activation.
Previously the structures of the archetype of the caspase
family, caspase 1, a member of specificity group I, and
caspase 3, a member of specificity group II, had been
described [17–22]. The first phase of the specificity
picture is now complete with the molecular structure of
caspase 8, a member of specificity group III, reported in
the September issue of Structure with Folding & Design by
two independent groups [23,24]. Overall, the structures
agree well, and reveal a fold that can be superimposed
with an impressive degree of precision on the structures of
caspases 1 and 3. The crystal forms are composed of two
catalytic domains, the second rotated approximately 180°
around the Z axis with respect to the first. The two cat-
alytic sites are apparently equal and independent, and
each contains two chains (Figure 2). It is not clear why the
proteins are dimeric, indeed this is unusual in proteases.
Not surprisingly, the most significant deviations between
the three caspases are in the specificity-determining
surface loops that define the substrate crevice. Unfortu-
nately the two reports have used different designations
for the loops, and also differing numbering systems. For
consistency, I use the consensus caspase 1 numbering
system, and the loop convention suggested by Rotonda
and colleagues in their caspase 3 structure [19]. These
agree with the caspase 8 structure description of Blan-
chard et al., and I have placed the descriptions by Watt 
et al. in parentheses. In future, it would be most useful if
descriptions of new caspase structures follow the estab-
lished caspase 1 numbering consensus and caspase 3
loop convention.
Expected specificity determinants: the S1 pocket
The first step in proteolysis is to position the scissile
peptide bond across the catalytic apparatus, and protease
families have developed distinct surface pockets that
allow them to position the substrate. Thus the primary
specificity of matrix metalloproteases is dominated by a
hydrophobic S1′ pocket, members of the papain family
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Figure 1
Caspase pathways. All caspase activation takes
place within the cell, primarily in the cytoplasm.
The apoptotic pathways are indicated by a pink
background, and the cytokine pathway by a
blue one. In the extrinsic apoptotic pathway
death is signaled by direct ligand-enforced
clustering of receptors at the cell surface, which
leads to the recruitment of adapter proteins (red
circles) and activation of the initiator caspase 8.
This caspase then directly activates the
executioner caspases 3 and 7 (and possibly 6),
which are predominantly responsible for the
limited proteolysis that characterizes apoptotic
dismantling of the cell. Alternatively, irreparable
damage to the genome caused by mutagens,
pharmaceuticals that inhibit DNA repair, or
ionizing radiation leads to the activation of
another initiator, caspase 9, and the intrinsic
pathway. The latter event requires the
recruitment of pro-caspase 9 to proteins such
as Apaf-1 (blue oblong with a red head), which
requires pro-apoptotic factors such as
cytochrome c to be released from mitochondria.
Although other modulators probably regulate
the apoptotic pathway in a cell-specific manner,
this framework is considered common to most
mammalian cells.
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have a dominant S2 pocket, and serine proteases have a
dominant S1 pocket. Perhaps the closest approach to the
caspase solution for substrate binding is found in the sub-
tilisins, which utilize a combination of S1 and S4 pockets
to derive specificity, although the high selectivity in the
caspases both in S1 and S4 is unparalleled. The caspases
are the most selective of limited proteases so far known,
and they have never been seen to cut more than just a few
bonds in their target protein substrates. What are the mol-
ecular determinants of this extreme specificity?
On the basis of almost total conservation throughout the
caspase family of residues that line the primary specificity
(S1) pocket of caspase 1, it was expected that this pocket
would be conserved. Thus, the all-important Arg179(260),
Arg341(413) and Gln283(358) form a patch of positive
charge and a hydrogen-bonding network to form a well-
defined pocket that readily accepts the Asp sidechain of a
substrate or inhibitor. 
Unexpected specificity determinants
Less expected are the determinants of the S4 pocket,
which is thought to distinguish between caspase groups.
If one examines the various caspase crystal structures it is
quite easy to see how the P4 sidechain makes specific
interactions in the S4 pocket. However, predicting these
interactions, as pointed out in the caspase 8 papers, was
not so easy. Indeed, there may be some overzealousness
to see how the S4 determinants could account for a speci-
ficity for Ile in caspase 8, but Asp in caspase 3. Part of
Thornberry’s work actually demonstrated that the Ki
ratio for the inhibitors Ac-DEVD-CHO and Boc-IETD-
CHO was about 0.001 for caspase 3, but about 1 for
caspase 8 [16]. Of course, the nature of the N-terminal
blocking group and different P2 residue may have
affected the Kis, but the result seems to demonstrate that
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Figure 2
Caspase activation by proteolysis. Caspases
are synthesized as single-chain precursors that
await activation within the cell. Activation
usually proceeds in all caspases by cleavage
at the conserved Asp297 (caspase 1
numbering convention) between the large
chain (cyan) and the small chain (pink) of the
catalytic subunit. Following this, an as yet
undescribed conformational change is thought
to occur, which brings the activity and
specificity determinants (quarter circles in the
linear precursor) into the correct alignment for
catalysis. Cys285 is the catalytic nucleophile,
and His237 is the general base. Frequently an
N-terminal peptide (N-peptide) is removed,
although the reason for this is obscure as it is
apparently not required for zymogen activation.
The crystal structures of caspases 1, 3 and 8
reveal a dimer of small and large subunits in
the active, processed state, and it is assumed,
though not specifically demonstrated, that this
is the case for caspases in solution. The active
sites in the putative dimer are shown as open
yellow circles.
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Table 1
Caspase substrate specificities.
P4 P3 P2 P1 
Group I: Cytokine activators W/L/Y E H D
Casp1
Casp4
Casp5
Group II: Apoptotic executioners D E X D
Casp3
Casp7
Casp2
Group III: Apoptotic initiators I/L/V E X D
Casp8
Casp9
Casp10
Casp6
This table, abstracted from Thornberry’s work [15,16], helps to
categorize the three caspase specificity groups in terms of their
extended subsite preferences (P1 through P4). Note that it also
groups them in order, with the apoptotic initiators and executioners in
separate groups. Caspases 2 and 6 (italics) seem to be out of place in
this grouping, as current data favor an initiating role for caspase 2, and
an execution one for caspase 6 (reviewed in [4]). The human caspase
13 is not listed here, as its specificity has yet to be reported. P1 refers
to the substrate residue adjacent to the scissile bond, and other
residues are numbered sequentially towards the N terminus of the
substrate. Pockets on the enzyme that accept the residues are given
the equivalent ‘S’ designation.
caspase 8 does not really distinguish between Ile or Asp
at P4, although large hydrophobes are certainly not well
tolerated. One possibility is that the S4 pocket of caspase
8 is quite plastic, and sidechain or even mainchain shifts
can accommodate widely distinct substrate sidechains.
Whence the specificity of caspase 8, then? One appealing
suggestion is that the P3 Glu is more important in
caspase 8 than in caspases 1 or 3. This can be seen both
kinetically from Thornberry’s work [15,16], and in the
additional interaction of the P3 Glu sidechain of the
bound inhibitor with a caspase 8-specific Arg177
sidechain on a surface loop reported in the structure by
Blanchard et al. [23]. 
Unexplored determinants
Certain caveats must be raised concerning the specificity
determinants. One of these comes from the report that
caspase 2 has very little activity on tetrapeptide substrates
and inhibitors [15,16,25], but that extension of substrates
to at least P5 is required [25]. Moreover, no studies have
systematically explored the primed side (the C-terminal
side) of the scissile bond. This is partly because of the
technical difficulty in synthesizing inhibitors or easily
detectable substrates to explore these potential interac-
tions, and partly because caspase 1 was reported not to
gain in catalysis by primed-side interactions [2]. However,
there are pockets on the surface of caspases 1, 3 and 8 that
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Figure 4
Same fold, different substrate-binding
solutions. Surface-charge diagrams (red,
negative; blue, positive) of (a) a single
catalytic domain of caspase 3 and 
(b) the bacterial protease Rgp2 produced
using the program GRASP. I thank Andreas
Eichinger for providing the Rgp2 figure. Both
models are on the same charge and size
scale, and the clear difference in surface
charge between the two proteases is evident.
The highly negative surface of Rgp2, with its
associated acidic S1 pocket in the middle of
the protein, is well adapted to attract Arg-
containing substrates. The opposite is seen in
caspase 3, where the less highly charged
surface has a highly basic S1 pocket. Thus it
has been possible to place radically different
protease specificities on the caspase fold.
Figure 3
Caspase specificity pockets. This stereoview
surface representation of caspase 3
showing the large chain of one catalytic
domain in cyan and the associated small
chain in pink was produced using the
program INSIGHT. Both chains of the
second catalytic domain are shown in gray,
with the associated active site in red. The
view looks down onto the substrate canyon,
with the inhibitor Ac-DEVD-CHO shown in
ball-and-stick representation running from
left to right in the standard orientation.
Acidic sidechains are colored red, with the
P1 Asp buried in the S1 pocket adjacent to
the yellow patch (which represents the
surface of the catalytic Cys and His
residues). The north rim of the canyon, which
accepts the P2 and P4 substrate
sidechains, is very pronounced in caspase 3,
and much less so in caspase 1, with
caspase 8 being intermediate. The south rim
accepts the P3 sidechain, and is more
pronounced in caspase 8. Significantly, the
unprimed pockets are composed of units
from the small chain. Putative primed
pockets, to the east of the catalytic dyad, are
evident in this representation, and would be
formed by units of the large chain. Some of
these putative pockets must be occupied in
a natural protein substrate, although in all
caspase structures the use of unprimed-side
inhibitors does not allow one to see them.
could certainly accept P1′ and P2′ substrate residues
(Figure 3), and it is tempting to assume that these could
be specificity determinants.
Caspase homologs — where are the relatives?
Caspases, from worms to flies to humans, are easily recog-
nized by sequence conservation (and where appropriate,
topology) of the catalytic domains. However, none has
been found in plants or microbes, and so their origin is a
bit of a mystery. Again, crystallography has come to the
rescue with the first example of a divergent protein placed
on the caspase fold — an Arg-specific cysteine protease
(Rgp2) from the bacterium Porphyromonas gingivalis [26].
Interestingly, this protein could not have been connected
with caspases on the basis of current sequence or folding
search algorithms, but it has a clear caspase fold even
though it exists in the crystal form as a monomer. An
N-terminal domain of Rgp2 adopts the position occupied
by the second catalytic domain in the caspase dimer, but
otherwise the proteins clearly originated by divergent evo-
lution. The Cys/His catalytic dyad of Rgp2 superimposes
well upon that of caspases 1 and 3, and it contains a well-
defined S1 pocket that accommodates an Arg residue
(Figure 4). This completely opposite primary specificity is
determined by an Asp sidechain that originates from the
same general area as Arg179 in the caspases. So it seems
that we can expect more caspase relatives, perhaps with
totally different, but dominant, S1 specificities, as more
protease structures become available. These may include
the bacterial Arg-specific protease clostripain and the
plant and animal Asn-specific legumains, as suggested by
Barrett and colleagues [27].
Acknowledgements
I thank Andreas Eichinger and Wolfram Bode for providing data on Rgp2
before publication.
References
1. Cerretti, D.P., et al., & Black, R.A. (1992). Molecular cloning of the
interleukin-1b converting enzyme. Science 256, 97-100.
2. Thornberry, N.A., et al., & Tocci, M.J. (1992). A novel heterodimeric
cysteine protease is required for interleukin-1beta processing in
monocytes. Nature 356, 768-774.
3. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. & Horvitz, H.M. (1993).
The C. elegans cell death gene ced-3 encodes a protein similar to
mammalian interleukin-1b-converting enzyme. Cell 75, 641-652.
4. Salvesen, G.S. & Dixit, V.M. (1997). Caspases: Intracellular signaling
by proteolysis. Cell 91, 443-446.
5. Green, D.R. (1998). Apoptotic pathways: the roads to ruin. Cell
94, 695-698.
6. Thornberry, N.A. & Lazebnik, Y. (1998). Caspases: enemies within.
Science 281, 1312-1316.
7. Ashkenazi, A. & Dixit, V.M. (1998). Death receptors: signaling and
modulation. Science 281, 1305-1308.
8. Liu, X., Kim, C.N., Yang, J., Jemmerson, R. & Wang, X. (1996).
Induction of apoptotic program in cell-free extracts: requirement for
dATP and cytochrome c. Cell 86, 147-157.
9. Zou, H., Henzel, W.J., Liu, X., Lutschg, A. & Wang, X. (1997). Apaf-1,
a human protein homologous to C. elegans CED-4, participates in
cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
10. Wolf, B.B. & Green, D.R. (1999). Suicidal tendencies: apoptotic cell
death by caspase family proteinases. J. Biol. Chem.
274, 20049-20052.
11. Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S. & Dixit,
V.M. (1998). An induced proximity model for caspase-8 activation
J. Biol. Chem. 273, 2926-2930.
12. Yang, X., Chang, H.Y. & Baltimore, D. (1998). Autoproteolytic
activation of pro-caspase by oligomerization. Mol. Cell 1, 319-325.
13. Li, P., et al., & Wang, X. (1997). Cytochrome c and dATP-dependent
formation of apaf-1/caspase-9 complex initiates an apoptotic protease
cascade. Cell 91, 479-489.
14. Stennicke, H.R., et al., & Salvesen, G.S. (1999). Caspase-9 can be
activated without proteolytic processing. J Biol Chem
274, 8359-8362.
15. Thornberry, N.A., et al., & Nicholson, D.W. (1997). A combinatorial
approach defines specificities of members of the caspase family and
granzyme B. J. Biol. Chem. 272, 17907-17911.
16. Garcia-Calvo, M., et al., & Thornberry, N.A. (1998). Inhibition of human
caspases by peptide-based and macromolecular inhibitors. J. Biol.
Chem. 273, 32608-32613.
17. Walker, N.P.C., et al., & Möller, A. (1994). Crystal structure of the
cysteine protease interleukin-1beta-converting enzyme: A (p20/p10)2
homodimer. Cell 78, 343-352.
18. Wilson, K.P., et al., & Livingston, D.J. (1994). Structure and
mechanism of interleukin-1 beta converting enzyme. Nature
370, 270-275.
19. Rotonda, J., et al., & Becher, J.W. (1996). The three-dimensional
structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct.
Biol. 3, 619-625.
20. Mittl, P.R., et al., & Grütter, M.G. (1997). Structure of recombinant
human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-
Asp fluoromethyl ketone. J. Biol. Chem. 272, 6539-6547.
21. Margolin, N., et al., & Livingston, D.J. (1997). Substrate and inhibitor
specificity of interleukin-1 beta-converting enzyme and related
caspases. J. Biol. Chem. 272, 7223-7228.
22. Okamoto, Y., et al., & Isomura, Y. (1999). Peptide based interleukin-1
beta converting enzyme (ICE) inhibitors: synthesis, structure activity
relationships and crystallographic study of the ICE-inhibitor complex.
Chem. Pharm. Bull. 47, 11-21.
23. Blanchard, H., et al., & Grütter, M.G. (1999). The three-dimensional
structure of caspase-8: an initiator enzyme in apoptosis. Structure
7, 1125-1133.
24. Watt, W., et al., & Watenpaugh, K.D. (1999). The atomic resolution
structure of human caspase-8, a key activator of apoptosis. Structure
7, 1135-1143.
25. Talanian, R.V., et al., & Wong, W.W. (1997). Substrate specificities of
caspase family proteases. J. Biol. Chem. 272, 9677-9682.
26. Eichinger, A., et al., & Bode, W. (1999). Crystal structure of gingipain
R: an Arg-specific bacterial cysteine proteinase with a caspase-like
fold. EMBO J. in press.
27. Chen, J.M., Rawlings, N.D., Stevens, R.A. & Barrett, A.J. (1998).
Identification of the active site of legumain links it to caspases,
clostripain and gingipains in a new clan of cysteine endopeptidases.
FEBS Lett. 441, 361-365.
Minireview  Initiation of apoptosis Salvesen    R229
